MYLUNG Consortium Study Protocol 2 | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
MYLUNG Consortium Study Protocol 2	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Active, not recruiting	Not stated	2026-05-18		NCT05644808

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
US Oncology Research	5

18 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Illinois Cancer Specialists	Niles	United States	17
Maryland Oncology Hematology, P.A.	Silver Spring	United States	7
Minnesota Oncology Hematology, P.A.	Minneapolis	United States	9
New York Oncology Hematology, P.C.	Albany	United States	3
Oncology Hematology Care Clinical Trials, LLC	Cincinnati	United States	6
Rocky Mountain Cancer Center	Denver	United States	13
Southern Cancer Center, PC	Daphne	United States	6
Texas Oncology - Fort Worth Cancer Center	Fort Worth	United States	7
Texas Oncology - West Texas	Abilene	United States	9
Texas Oncology- DFWW	Arlington	United States	1
Texas Oncology- Northeast Texas	Tyler	United States	6
Texas Oncology-Baylor Charles A. Sammons Cancer Center	Dallas	United States	14
Texas Oncology-Dallas Presbyterian Hospital	Dallas	United States	2
Texas Oncology-McAllen	McAllen	United States	3
Virginia Cancer Specialists, PC	Fairfax	United States	35
Virginia Oncology Associates	Newport News	United States	11
Willamette Valley Cancer Institute and Research Center	Eugene	United States	17
Woodlands Medical Specialists, PA	Pensacola	United States	6